Chlorhexidine Drying Time

NCT02095535 | Completed Results

• 1 other identifier: H14-00623
• Study Type: observational
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

Before a patient gets a spinal/epidural, their lower back is cleaned with an antiseptic solution diluted in alcohol called ChloraPrep. ChloraPrep must completely dry before starting the anesthetic procedure. It is not known how much time is needed for the solution to completely dry. The investigators aim to determine this. As the ChloraPrep dries, the alcohol is converted into vapour. The investigators will be using a PPBRae 3000 device to detect small amounts of vapours in the air. As the ChloraPrep dries it gives off less and less vapour. The investigators will use this diminishing vapour concentration to determine when drying is complete.

Conditions

Drying Time

Keywords

obstetric patients; chloraprep; chlorhexidine; drying time

Outcome Measures

Primary Outcomes (1)

• Length of Drying Time

  Length of drying time from when Chloraprep solution is applied to skin to when skin is deemed dry.

  At Chloraprep application

Study Arms (1)

Study group

All study participants

Drug: Chlorhexidine gluconate

Interventions

Chlorhexidine gluconate DRUG

antiseptic

Also known as: Chloraprep

Study group

Eligibility Criteria

• Age: 19 Years - 40 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Elective cesarean patients at BC Women's Hospital

You may qualify if:

• Pregnant
• At full term
• Due to have a cesarean section under spinal or epidural anesthesia
• to 40 years of age

You may not qualify if:

• Allergy to certain antiseptic solutions
• Not suitable for a spinal/epidural anesthetic
• Have a significant amount of hair on lower back

Sponsors & Collaborators

• University of British Columbia: lead

Study Sites (1)

BC Women's Hospital

Vancouver, British Columbia, V6H 3N1, Canada

Location

MeSH Terms

Interventions

chlorhexidine gluconate

Limitations and Caveats

* Small sample size * Severe methodological assumptions (i.e. measuring of ChloraPrep drying time, lack of gold standard to assess wetness/dryness * Patient's variables could influence wetness * No enrollment of high BMI patients with skin folds

Results Point of Contact

• Title: Tashya De Silva
• Organization: UBC Department of Anesthesia - BC Women's Hospital

tashya.desilva@cw.bc.ca

604-875-2158

Study Officials

• Vit Gunka, MD FRCPC

  University of British Columbia

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principle Investigator

Study Record Dates

• First Submitted: March 19, 2014
• First Posted: March 24, 2014
• Study Start: April 1, 2014
• Primary Completion: June 1, 2014
• Study Completion: June 1, 2014
• Last Updated: August 7, 2017
• Results First Posted: August 7, 2017

Record last verified: 2017-04

Locations

CA (1)